Inventor
SMITH CHASE C
US20 patents
⚠️ This page may combine multiple inventors who share the name “SMITH CHASE C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
FORMA TM LLC
6 patentsUS10772874B2Sep 15, 2020
Compounds and compositions for the inhibition of NAMPT
FORMA TM LLC6 citations83
US10647695B2May 12, 2020
Compounds and compositions for the inhibition of NAMPT
FORMA TM LLC5 citations83
US10456382B2Oct 29, 2019
Compounds and compositions for the inhibition of NAMPT
FORMA TM LLC7 citations83
US10329275B2Jun 25, 2019
Compounds and compositions for the inhibition of NAMPT
FORMA TM LLC8 citations83
US10272072B2Apr 30, 2019
Compounds and compositions for the inhibition of NAMPT
FORMA TM LLC11 citations83
US10696692B2Jun 30, 2020
Amido-benzyl sulfone and sulfoxide derivates
FORMA TM LLC6 citations72
VALO HEALTH INC
4 patentsUS11279687B2Mar 22, 2022
Compounds and compositions for the inhibition of NAMPT
VALO HEALTH INC2 citations73
US11547701B2Jan 10, 2023
Compounds and compositions for the inhibition of NAMPT
VALO HEALTH INC2 citations72
US12336981B2Jun 24, 2025
Compounds and compositions for the inhibition of NAMPT
VALO HEALTH INC0 citations62
US11479564B2Oct 25, 2022
Piperidine derivatives and compositions for the inhibition of nicotinamide phosphoribosyltransferase (NAMPT)
VALO HEALTH INC1 citations61
BAIR KENNETH W
3 patentsUS9676721B2Jun 13, 2017
Compounds and compositions for the inhibition of NAMPT
BAIR KENNETH W33 citations93
US9169209B2Oct 27, 2015
Compounds and compositions for the inhibition of NAMPT
BAIR KENNETH W25 citations90
US9555039B2Jan 31, 2017
Piperidine derivatives and compositions for the inhibition of nicotinamide phosphoribosyltransferase (NAMPT)
BAIR KENNETH W13 citations82
NOVO NORDISK HEALTHCARE AG
3 patentsUS11980611B2May 14, 2024
Treating sickle cell disease with a pyruvate kinase R activating compound
NOVO NORDISK HEALTHCARE AG3 citations85
US12071440B2Aug 27, 2024
Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators
NOVO NORDISK HEALTHCARE AG0 citations62
US12053458B2Aug 6, 2024
Treating sickle cell disease with a pyruvate kinase R activating compound
NOVO NORDISK HEALTHCARE AG0 citations62